Transcode Therapeutics logo

Transcode Therapeutics share price today

(RNAZ)

Transcode Therapeutics share price is $3.52 & ₹299.90 as on 25 Dec 2024, 2.30 'hrs' IST

$3.52

-0.06

(-1.68%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Transcode Therapeutics share price in Dollar and Rupees. Guide to invest in Transcode Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Transcode Therapeutics. Get details on the Indian mutual funds that are investing in Transcode Therapeutics. Get Analyst recommendations and forecasts along with all the Transcode Therapeutics's financials.

Transcode Therapeutics share price movements

  • Today's Low: $3.34
    Today's High: $3.74

    Day's Volatility :10.77%

  • 52 Weeks Low: $3.21
    52 Weeks High: $250.80

    52 Weeks Volatility :98.72%

Transcode Therapeutics Returns

PeriodTranscode Therapeutics IncIndex (Russel 2000)
3 Months
-82.66%
0.0%
6 Months
-89.44%
0.0%
1 Year
-98.53%
0.0%
3 Years
-99.99%
-21.1%

Transcode Therapeutics Key Statistics

in dollars & INR

Previous Close
$3.58
Open
$3.62
Today's High
$3.7431
Today's Low
$3.3401
Market Capitalization
$2.5M
Today's Volume
$46.6K
52 Week High
$250.8
52 Week Low
$3.21
Revenue TTM
$0.0
EBITDA
$-17.7M
Earnings Per Share (EPS)
$5571.72
PE Ratio
0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1048.7%

How to invest in Transcode Therapeutics from India?

It is very easy for Indian residents to invest directly in Transcode Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Transcode Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Transcode Therapeutics or RNAZ on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Transcode Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Transcode Therapeutics shares which would translate to 0.242 fractional shares of Transcode Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Transcode Therapeutics, in just a few clicks!

Returns in Transcode Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Transcode Therapeutics investment value today

Current value as on today

₹3,704

Returns

₹96,296

(-96.3%)

Returns from Transcode Therapeutics Stock

₹98,535 (-98.53%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Transcode Therapeutics

300.0%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Transcode Therapeutics from India has grown in the last 30 days as on Dec 26, 2024. 300.0% more purchase transactions for Transcode Therapeutics in the last 30 days versus the previous period.

110%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Transcode Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 110% more investors are searching Transcode Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Transcode Therapeutics

  • Geode Capital Management, LLC

    0.71%

  • PRIVATE CAPITAL MANAGEMENT LLC

    0.47%

  • Sheets Smith Wealth Management

    0.29%

  • Virtu Financial LLC

    0.11%

  • Ronna Sue Cohen

    0.10%

  • CapTrust Financial Advisors

    0.09%

Analyst Recommendation on Transcode Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Transcode Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Transcode Therapeutics

What analysts predicted

Upside of 468.18%

Current:

$3.52

Target:

$20.00

Insights on Transcode Therapeutics

  • Price Movement

    In the last 7 days, RNAZ stock has moved down by -8.6%
  • RNAZ vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 125.8%
  • RNAZ vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 125.2%

Transcode Therapeutics Technicals Summary

Sell

Neutral

Buy

Transcode Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Transcode Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Transcode Therapeutics Inc
-71.71%
-89.44%
-98.53%
-99.99%
-100.0%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Transcode Therapeutics Inc
0.0
0.0
NA
-4.76
-10.49
-2.08
NA
2.62
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Transcode Therapeutics Inc
Buy
$2.5M
-100.0%
0.0
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Transcode Therapeutics

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.
Organization
Transcode Therapeutics
Employees
10
CEO
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D.
Industry
Miscellaneous

Management People of Transcode Therapeutics

NameTitle
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D.
Executive Chairman of the Board
Mr. Thomas A. Fitzgerald M.B.A.
Interim CEO, CFO, President, VP of Administration & Director
Dr. Zdravka Medarova Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Anna Moore Ph.D.
Co-Founder, Scientific Advisor & Member of Scientific Advisory Board
Ms. Susan Duggan M.B.A., R.N.
Senior Vice President of Operations
Dr. Daniel R. Vlock M.D.
Chief Medical Officer

Important FAQs about investing in Transcode Therapeutics from India :

What is Transcode Therapeutics share price today?

Transcode Therapeutics share price today stands at $3.52, Open: $3.62 ; Previous Close: $3.58 ; High: $3.74 ; Low: $3.34 ; 52 Week High: $250.80 ; 52 Week Low: $3.21. The stock opens at $3.62, after a previous close of $3.58. The stock reached a daily high of $3.74 and a low of $3.34, with a 52-week high of $250.80 and a 52-week low of $3.21.

Can Indians buy Transcode Therapeutics shares?

Yes, Indians can invest in the Transcode Therapeutics (RNAZ) from India.

With INDmoney, you can buy Transcode Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Transcode Therapeutics at zero transaction cost.

How can I buy Transcode Therapeutics shares from India?

It is very easy to buy Transcode Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Transcode Therapeutics be purchased?

Yes, you can buy fractional shares of Transcode Therapeutics with INDmoney app.

What are the documents required to start investing in Transcode Therapeutics stocks?

To start investing in Transcode Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Transcode Therapeutics

Today’s highest price of Transcode Therapeutics (RNAZ) is $3.74.

Today’s lowest price of Transcode Therapeutics (RNAZ) is $3.34.

What is today's market capitalisation of Transcode Therapeutics

Today's market capitalisation of Transcode Therapeutics RNAZ is 2.5M

What is the 52 Week High and Low Range of Transcode Therapeutics

  • 52 Week High

    $250.80

  • 52 Week Low

    $3.21

What are the historical returns of Transcode Therapeutics?

  • 1 Month Returns

    -71.71%

  • 3 Months Returns

    -89.44%

  • 1 Year Returns

    -98.53%

  • 5 Years Returns

    -100%

Who is the Chief Executive Officer (CEO) of Transcode Therapeutics

Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D. is the current Chief Executive Officer (CEO) of Transcode Therapeutics.